ADC Telecommunications

Hot Off The Wires

Atreca to Present at Upcoming Investor Conferences 5/19/2022

Mersana Therapeutics Announces FDA Grant of Orphan Drug Designation to XMT-2056 … 5/19/2022

Pyxis Oncology Announces Presentations at Upcoming Investor Conferences 5/19/2022

Sandvine Announces Four Key Enhancements to Application and Network Intelligence 5/17/2022

Turning Point Therapeutics Announces Appointment of Steve Sabus as Chief Commercial Officer 5/16/2022

Pyxis Oncology Reports Financial Results for the Quarter Ended March 31, 2022 … 5/13/2022

Vincerx Pharma Reports First Quarter 2022 Financial Results and Provides a Corporate … 5/12/2022

Lantern Pharma to Host Virtual KOL Event on Glioblastoma Multiforme (GBM) with … 5/12/2022

Artery Technology Launches AT32WB415 Series Bluetooth 5.0 MCU 5/11/2022

Turning Point Therapeutics Reports First-Quarter 2022 Financial Results, Provides Operational Updates 5/10/2022

Turning Point Therapeutics Granted Breakthrough Therapy Designation for Repotrectinib Treatment in Patients … 5/10/2022

Sutro Biopharma Reports First Quarter 2022 Financial Results, Business Highlights, and Anticipated … 5/9/2022

Mersana Therapeutics Provides Business Update and Announces First Quarter 2022 Financial Results 5/9/2022

Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 5/6/2022

CytomX Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Update 5/5/2022

more news »

Quicklinks